Glow Protocol
Also known as: GLOW
Multi-Peptide Skin Rejuvenation Complex
Overview
Combination featuring BPC-157, TB-500, and GHK-Cu marketed for skin rejuvenation and anti-aging. Individual components have research support, but combination protocols require careful dosing to avoid exceeding therapeutic ranges.
Key benefits
- Single injection delivers multiple regenerative peptides
- Theoretical additive effects from combined components
- Convenience factor versus individual peptide administration
Mechanism of action
BPC-157 provides anti-inflammatory effects; TB-500 supports angiogenesis; GHK-Cu stimulates collagen production. Fixed-ratio combinations may deliver individual peptides outside optimal therapeutic ranges.
Molecular data
- Type
- Fixed-ratio peptide combination
Sequence
BPC-157 + TB-500 + GHK-Cu blend
Blend composition
What is in the vial, and in what proportion. Each component has its own reference page.
Total 70 mg per vial.
Indications
What the research community uses this compound for, with self-reported effectiveness.
Primary Applications
Skin Rejuvenation
Most effectiveTheoretical synergistic effects; formal combination studies are limited
Wound Healing
EffectiveBPC-157 and TB-500 components support tissue regeneration
Anti-Aging
EffectiveGHK-Cu stimulates collagen production
Dosing protocols
Common protocols by delivery method. Adjust the curve below to model accumulation in your own cycle.
Injectable
Subcutaneous injection to abdominal area, outer thigh, or upper arm.
| Protocol | Dose | Frequency | Route / duration |
|---|---|---|---|
| Standard protocol | Per formulation instructions | Once daily | Subcutaneous |
Preparation
You will need
- Bacteriostatic water
- Insulin syringes
- Alcohol prep pads
Steps
- Clean vial top with alcohol pad
- Add bacteriostatic water as directed
- Gently swirl - do not shake
- Solution should appear clear
- Store refrigerated immediately
Work out the water volume and syringe units in the reconstitution calculator →
Interactions
Pairwise interactions with other compounds you might be cycling — the same data behind the cycle builder's safety check.
Individual GHK-Cu
AvoidRisk of copper overdose when combining products
Retinoids
MonitorMay increase skin sensitivity; monitor for irritation
Individual BPC-157
MonitorTotal daily intake may exceed therapeutic ranges
NAD+
CompatibleDifferent mechanisms may complement cellular energy support
Vitamin C
CompatibleAntioxidant support compatible with peptide effects
Timeline
Typical week-by-week effects reported in clinical and observational data.
- Week 1-2
Initial tissue healing response begins
- Week 2-4
Visible skin improvements may begin
- Week 4-8
Collagen synthesis and regeneration effects
- Week 8-12
Peak effects; optimal skin rejuvenation
Safety
Reported adverse effects, contraindications, and what to monitor on cycle.
Common side effects
- Injection site reactions
- Temporary blue-green discoloration (from GHK-Cu)
Rare side effects
- Potential copper accumulation effects
- Individual peptide intolerance symptoms
Stop signs — stop and seek advice
- Severe injection site reactions or infection
- Allergic reactions (rash, difficulty breathing)
- Signs of copper toxicity (nausea, jaundice)
Quality checks
What a legitimate product looks like, what should give pause, and what should make you stop.
Good signs
- Clear solution without particles
- Proper packaging stating individual peptide amounts
Warning signs
- Verify peptide content matches supplier specifications
- Calculate individual peptide doses before starting
Stop signs — don't use
- Excessive individual peptide amounts exceeding recommended ranges
- Cloudy or discolored solution
Recent research
Newer papers and trial readouts on file for this compound, with source and date.
March 2025 · Alternative Therapies in Health and Medicine
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study
First human IV safety study showed no adverse effects at doses up to 20 mg in healthy adults, with no impact on heart, liver, kidney, thyroid, or glucose biomarkers.
July 2025 · HSS Journal
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Systematic review of 36 studies found BPC-157 enhances GH receptor expression and angiogenesis, improving functional and biomechanical outcomes in musculoskeletal injury models.
February 2025 · Journal of Peptide Science
Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective
Review of GHK-Cu's tissue regeneration and collagen-stimulating properties, noting strong preclinical evidence but a surprising absence of formal clinical trials for topical anti-aging use.
References
Primary literature and clinical-trial data informing this entry.
Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth
Staresinic M, Sebecic B, Patrlj L, et al. · Journal of Orthopaedic Research · 2003
BPC-157 improved Achilles tendon recovery biomechanically, functionally, and microscopically; reversed HNE-mediated growth inhibition of tendocytes.
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Pickart L, Vasquez-Soltero JM, Margolina A · International Journal of Molecular Sciences · 2018
GHK-Cu modulates over 4,000 human genes, stimulates collagen, elastin, and GAG synthesis, and promotes tissue repair across skin, lung, bone, liver, and stomach.
A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin β4 in healthy Chinese volunteers
Wang X, Liu L, Qi L, et al. · Journal of Cellular and Molecular Medicine · 2021
Phase I trial in 54 healthy subjects demonstrated recombinant thymosin β4 was well tolerated and safe across ascending IV doses up to 25 μg/kg with no significant accumulation.
No Published Studies on GLOW Combination
N/A · 2024
No clinical or preclinical studies examine the three-peptide GLOW combination; all evidence is extrapolated from individual component research.
Last updated . How this page was sourced is described in the methodology.